Published in MBio on January 24, 2017
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet (1984) 11.51
Nitric oxide and the immune response. Nat Immunol (2001) 10.00
Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 7.26
Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature (2007) 5.82
The glyoxylate cycle is required for fungal virulence. Nature (2001) 4.70
Tissue-resident macrophages. Nat Immunol (2013) 4.09
L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol (2003) 2.91
Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem (2002) 2.62
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood (2004) 2.61
Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med (1992) 2.37
Phagocytosis by neutrophils induces an amino acid deprivation response in Saccharomyces cerevisiae and Candida albicans. Proc Natl Acad Sci U S A (2003) 2.19
Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog (2008) 2.19
Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog (2008) 2.14
Suppression of T-cell functions by human granulocyte arginase. Blood (2006) 1.85
Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect Immun (2011) 1.54
The pathogenetic significance of intestinal Candida colonization--a systematic review from an interdisciplinary and environmental medical point of view. Int J Hyg Environ Health (2002) 1.50
Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag (2014) 1.46
The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio (2011) 1.39
Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog (2010) 1.39
Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide (1999) 1.38
Arginine-induced germ tube formation in Candida albicans is essential for escape from murine macrophage line RAW 264.7. Infect Immun (2009) 1.38
Property differences among the four major Candida albicans strain clades. Eukaryot Cell (2009) 1.36
Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog (2013) 1.27
Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob Agents Chemother (2011) 1.25
Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation. PLoS Pathog (2014) 1.25
Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages. Clin Exp Immunol (1999) 1.08
Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J Leukoc Biol (2011) 1.07
Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care (2014) 1.04
Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog (2015) 1.02
Lipopolysaccharide-induced M2 to M1 macrophage transformation for IL-12p70 production is blocked by Candida albicans mediated up-regulation of EBI3 expression. PLoS One (2013) 1.00
Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas. Proc Natl Acad Sci U S A (2014) 0.99
Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels. Trends Microbiol (2014) 0.98
Interactions of fungal pathogens with phagocytes. Nat Rev Microbiol (2016) 0.96
The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury. Ann Surg (2014) 0.94
Suppression of type 2 NO-synthase activity in macrophages by Candida albicans. Int J Med Microbiol (2001) 0.93
Amino acid auxotrophy as a system of immunological control nodes. Nat Immunol (2015) 0.92
Regulation of NK cell function by human granulocyte arginase. J Immunol (2009) 0.92
Proteomic characterization of human proinflammatory M1 and anti-inflammatory M2 macrophages and their response to Candida albicans. Proteomics (2014) 0.91
Candida albicans suppresses nitric oxide generation from macrophages via a secreted molecule. PLoS One (2014) 0.91
Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections. Mucosal Immunol (2014) 0.90
Neutrophil Attack Triggers Extracellular Trap-Dependent Candida Cell Wall Remodeling and Altered Immune Recognition. PLoS Pathog (2016) 0.87
Abrogation of IL-4 receptor-α-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing T(h)2 response. Int Immunol (2013) 0.85
Antifungal Th Immunity: Growing up in Family. Front Immunol (2014) 0.83
Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1. J Immunol (2015) 0.81
The crucial role of l-arginine in macrophage activation: What you need to know about it. Life Sci (2015) 0.80
Effect of in vitro monocyte activation by Listeria monocytogenes antigens on phagocytosis and production of reactive oxygen and nitrogen radicals in bovines. Vet Immunol Immunopathol (1998) 0.78
Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils. Clin Chem Lab Med (2014) 0.77